% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • manipru manipru Dec 30, 2012 9:54 AM Flag

    Re: where are all the shorts????



    December 20, 2012

    07:31 EDT FOLD Amicus Theraputics weakness a buying opportunity, says JPMorgan JPMorgan views the pullback in shares of Amicus Theraputics on the company's Phase 3 trial miss as a buying opportunity. The firm says migalastat is active in Fabry and safe, and reiterates an Overweight rating on the stock, despite lowering its price target for shares to $5 from $9.

    btw... do you (rat) know if Amicus is presenting again at the JP Morgan Healthcare Conference next week? Listed as an event on their website...

    ;-) ;-)

    This topic is deleted.
7.52+0.02(+0.27%)Oct 25 4:00 PMEDT